{"id":"W4396514095","doi":"10.51731/cjht.2024.879","title":"Niraparib and Abiraterone Acetate (Akeega)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Abiraterone acetate; Reimbursement; Medicine; Abiraterone; Prostate cancer; Asymptomatic; Internal medicine; Oncology; Chemotherapy; Cancer; Gynecology; Political science; Androgen deprivation therapy; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001901458,0.0002769669,0.0005803176,0.001667636,0.0003439341,0.001301652,0.0004242421,0.0004105075,0.005027557],"category_scores_gemma":[0.003671448,0.0001155161,0.0007461637,0.002075757,0.0002797257,0.0004294495,0.0002663671,0.0006440225,0.0007721231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003503021,"about_ca_system_score_gemma":0.007370412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03550634,"about_ca_topic_score_gemma":0.1677545,"domain_scores_codex":[0.9982133,0.000379279,0.0001832582,0.00007941965,0.001053226,0.00009156913],"domain_scores_gemma":[0.9978934,0.0005861949,0.0004932221,0.00004873976,0.0008827065,0.00009587882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005117237,0.00006677712,0.001550084,0.008710872,0.0003477487,0.0001399668,0.00005083319,0.0003781545,0.001894081,0.002845929,0.02733055,0.9561733],"study_design_scores_gemma":[0.0002468354,0.0007141734,0.0134161,0.006768994,0.0008300199,0.001193428,0.0001235099,0.0002423439,0.002775744,0.0009159945,0.9727377,0.00003509019],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.006433129,0.9431168,0.000643326,0.002455872,0.0004146544,0.0002067742,0.00160601,0.00005789917,0.04506559],"genre_scores_gemma":[0.07670709,0.8957708,0.003885944,0.002155674,0.0003880274,0.000162657,0.001890102,0.00001924136,0.01902052],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03550634,"threshold_uncertainty_score":0.07059932,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03726430238214361,"score_gpt":0.3268928820091913,"score_spread":0.2896285796270476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}